Correlation Between Day One and Phathom Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Day One and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Day One and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Phathom Pharmaceuticals.
Diversification Opportunities for Day One and Phathom Pharmaceuticals
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Day and Phathom is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Day One i.e., Day One and Phathom Pharmaceuticals go up and down completely randomly.
Pair Corralation between Day One and Phathom Pharmaceuticals
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.32 times more return on investment than Phathom Pharmaceuticals. However, Day One Biopharmaceuticals is 3.14 times less risky than Phathom Pharmaceuticals. It trades about -0.1 of its potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest 1,433 in Day One Biopharmaceuticals on August 24, 2024 and sell it today you would lose (99.00) from holding Day One Biopharmaceuticals or give up 6.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Phathom Pharmaceuticals
Performance |
| Timeline |
| Day One Biopharmaceu |
| Phathom Pharmaceuticals |
Day One and Phathom Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Phathom Pharmaceuticals
The main advantage of trading using opposite Day One and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.| Day One vs. Lyra Therapeutics | Day One vs. Hookipa Pharma | Day One vs. Cingulate Warrants | Day One vs. SAB Biotherapeutics |
| Phathom Pharmaceuticals vs. Lyra Therapeutics | Phathom Pharmaceuticals vs. Hookipa Pharma | Phathom Pharmaceuticals vs. Cingulate Warrants | Phathom Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |